0001819113-23-000033.txt : 20230502 0001819113-23-000033.hdr.sgml : 20230502 20230502162037 ACCESSION NUMBER: 0001819113-23-000033 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230428 FILED AS OF DATE: 20230502 DATE AS OF CHANGE: 20230502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pellizzari Christine A CENTRAL INDEX KEY: 0001127430 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39727 FILM NUMBER: 23879356 MAIL ADDRESS: STREET 1: 10 FINDERNE AVENUE CITY: BRIDGEWATER STATE: NJ ZIP: 08807 FORMER NAME: FORMER CONFORMED NAME: PELLIZZARI CHRISTINE A DATE OF NAME CHANGE: 20001030 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Science 37 Holdings, Inc. CENTRAL INDEX KEY: 0001819113 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 844278203 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 PARK OFFICES DRIVE STREET 2: SUITE 3606 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 BUSINESS PHONE: (984) 377-3737 MAIL ADDRESS: STREET 1: 800 PARK OFFICES DRIVE STREET 2: SUITE 3606 CITY: RESEARCH TRIANGLE PARK STATE: NC ZIP: 27709 FORMER COMPANY: FORMER CONFORMED NAME: Lifesci Acquisition II Corp. DATE OF NAME CHANGE: 20200723 4 1 wf-form4_168305881849181.xml FORM 4 X0407 4 2023-04-28 0 0001819113 Science 37 Holdings, Inc. SNCE 0001127430 Pellizzari Christine A 800 PARK OFFICES DRIVE, SUITE 3606 RESEARCH TRIANGLE PARK NC 27709 0 1 0 0 Chief Legal and HR Officer 0 Common Stock 2023-04-28 4 A 0 702332 A 709832 D Stock Option 9.49 2023-04-28 4 D 0 1270739 D 2031-07-20 Common Stock 1270739.0 0 D Stock Option 11.47 2023-04-28 4 D 0 238095 D 2032-01-07 Common Stock 238095.0 0 D Stock Option 10.05 2023-04-28 4 D 0 247000 D 2031-10-07 Common Stock 247000.0 0 D On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 1,270,739 shares of common stock of the issuer and in exchange issued to the reporting person 508,295 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock. On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 238,095 shares of common stock of the issuer and in exchange issued to the reporting person 95,237 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock. On April 28, 2023, the issuer cancelled, pursuant to the issuer's option exchange program, options to purchase 247,000 shares of common stock of the issuer and in exchange issued to the reporting person 98,800 restricted stock units, each of which represents a contingent right to receive one share of the issuer's common stock. Includes 2,500 shares acquired under the issuer's Employee Stock Purchase Plan. Includes 702,332 restricted stock units, which will vest in three equal annual installments beginning on April 28, 2024, subject to continued employment. The total amount has been adjusted to add 29 derivative securities that were not previously included due to a rounding error. /s/ Christine Pellizzari 2023-05-02